Brief: Candel Therapeutics Reports Second Quarter 2026 Financial Results And Recent Corporate Highlights
13/08/2026 13:39
BRIEF-Candel Therapeutics Reports Second Quarter 2026 Financial Results And Recent Corporate Highlights Aug 13 (Reuters) - Candel Therapeutics Inc CADL.O:
CANDEL THERAPEUTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS
Source text: ID:nGNX3KW5j4
Further company coverage: CADL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Candel Therapeutics
See all newsBrief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Candel Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Candel Therapeutics Reports Second Quarter 2026 Financial Results And Recent Corporate Highlights
Candel Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)